Palomino Laboratories Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-14.
Palomino Laboratories Inc. filed a Form D notice of an exempt securities offering with the SEC on October 14, 2025. The filing reports $11.60M sold. Its industry group is Other Technology. It names Jeffrey Shealy (Executive Officer, Director, Promoter), Steven DenBaars (Executive Officer, Director, Promoter), Richard Ogawa (Executive Officer, Director) (SEC Form D, October 14, 2025).
Is this your company?
Sell to companies like Palomino Laboratories Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Palomino Laboratories Inc.
Free to see. No signup.
More on the people and the money behind Palomino Laboratories Inc., from the filings we hold.
Other Technology raises by companies based in California, filed in October 2025, largest first.
Get an email when Palomino Laboratories Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Palomino Laboratories Inc. raises, hires or launches. No email unless you switch it on.
Watch Palomino Laboratories Inc. →Get the full cited report on Palomino Laboratories Inc.
What the filing shows about Palomino Laboratories Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Palomino Laboratories Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Palomino Laboratories Inc.'s address as 313 Bryant Court, Palo Alto, CA 94301.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Palomino Laboratories Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Palomino Laboratories Inc. See pricing
Palomino Laboratories Inc. is a registered filer with the SEC (CIK 1938569) and has filed since 2025-10-14. 2 filings are on record, the latest on 2026-05-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Palomino Laboratories Inc.'s Form D of 2025-10-14 names Jeffrey Shealy, Steven DenBaars, Richard Ogawa and 2 more as its officers, directors or promoters.
Its new offerings report $28.58M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 3844 filings in Other Technology, totalled by week.
Jeffrey Shealy is named as Executive Officer and Director and Promoter on the Form D that Palomino Laboratories Inc. filed with the SEC on 14 October 2025, one of 5 people that filing names.
Steven DenBaars is named as Executive Officer and Director and Promoter on the Form D that Palomino Laboratories Inc. filed with the SEC on 14 October 2025, one of 5 people that filing names.
Richard Ogawa is named as Executive Officer and Director on the Form D that Palomino Laboratories Inc. filed with the SEC on 14 October 2025, one of 5 people that filing names.
Jason Tu is named as Director on the Form D that Palomino Laboratories Inc. filed with the SEC on 14 October 2025, one of 5 people that filing names.
Nathan Pierra is named as Executive Officer and Director and Promoter on the Form D that Palomino Laboratories Inc. filed with the SEC on 14 October 2025, one of 5 people that filing names.
5 people named on the filing — 4 holding an executive role and 1 as a director only.
Named as of the 2025-10-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Palomino Laboratories Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Palomino Laboratories Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Palomino Laboratories Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Palomino Laboratories Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Palomino Laboratories Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Palomino Laboratories Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/palomino-laboratories-inc-form-d-25000001